Optimizing clinical use of biomarkers in high-risk acute heart failure patients

Factors Influencing the Predictive Power of Models for Predicting Mortality and/or Heart Failure Hospitalization in Patients With Heart Failure

(2014) Wouter Ouwerkerk et al.   JACC-Heart Failure

Risk Prediction in Patients With Heart Failure

(2014) Kazem Rahimi et al.   JACC-Heart Failure

Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results

(2013) Alan H.B. Wu et al.   AMERICAN HEART JOURNAL

Comparison of Characteristics and Outcomes of Patients With Heart Failure Preserved Ejection Fraction Versus Reduced Left Ventricular Ejection Fraction in an Urban Cohort

(2013) Rene Quiroz et al.   AMERICAN JOURNAL OF CARDIOLOGY

Predictors of Postdischarge Outcomes From Information Acquired Shortly After Admission for Acute Heart Failure

(2013) John G. Cleland et al.   Circulation-Heart Failure

Clinical use of novel biomarkers in heart failure: towards personalized medicine

(2013) Daniela Schmitter et al.   HEART FAILURE REVIEWS

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

(2013) Johan Lassus et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Post-Hospital Syndrome — An Acquired, Transient Condition of Generalized Risk

(2013) Harlan M. Krumholz   NEW ENGLAND JOURNAL OF MEDICINE

The Use of Biomarkers in the Patient with Heart Failure

(2013) Punam Chowdhury et al.   Current Cardiology Reports

Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction

(2011) Thomas J. Wang   CIRCULATION

Emerging Biomarkers in Heart Failure

(2011) R. R. J. van Kimmenade et al.   CLINICAL CHEMISTRY

Biomarkers: optimizing treatment guidance in heart failure

(2011) Michael Böhm et al.   Clinical Research in Cardiology

Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure

(2011) Domingo A. Pascual-Figal et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

(2011) Alan S. Maisel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction

(2011) Cord Manhenke et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

(2010) Ravi V. Shah et al.   EUROPEAN JOURNAL OF HEART FAILURE

Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea

(2010) Alan Maisel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

(2010) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

Multi-marker strategies in heart failure: clinical and statistical approaches

(2009) Larry A. Allen et al.   HEART FAILURE REVIEWS

Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

(2009) Beth Davison Weatherley et al.   JOURNAL OF CARDIAC FAILURE

Biomarkers in Heart Failure

(2008) Eugene Braunwald   NEW ENGLAND JOURNAL OF MEDICINE